Firmenbeschreibung
Merck & Co. Inc. ist ein forschungsorientiertes, globales Pharmaunternehmen, das ein breites Sortiment an neuartigen Medikamenten, Impfstoffen und biologischen Therapeutika erforscht, entwickelt, produziert und vermarktet. Das Angebot richtet sich vorwiegend an Krankenhäuser, Apotheken, Einzelhändler, Versicherungen, Regierungsverwaltungen oder institutionelle Einrichtungen aus dem Gesundheitswesen. Des Weiteren bietet Merck & Co. nicht-verschreibungspflichtige Medikamente, Produkte für die Fußpflege und Sonnenschutzmittel sowie Gesundheitsprodukte für Tiere an. Dabei bedient sich das Unternehmen der Biotechnologie, der Genforschung und der Gentherapie. Schwerpunkte sind die Behandlung von Allergien, Atemwegserkrankungen, Infektionskrankheiten, Krebs, Herz- und Kreislauferkrankungen, Erkrankungen des zentralen Nervensystems sowie Hautkrankheiten.
KeyData
endOfFinancialYear: | 31.12.2022 00:00 |
stockholderStructure: | Freefloat (83.84%),The Vanguard Group, Inc. (8.36%),BlackRock, Inc. (7.8%) |
sharesOutstanding: | 2535395974.0000 |
ceo: | Robert M. Davis |
board: | Caroline Litchfield, Cristal N. Downing, Dave Williams, Dr. Dean Y. Li, Frank Clyburn, Jennifer Zachary, Julie L. Gerberding, Michael A. Klobuchar, Richard R. DeLuca Jr., Sanat Chattopadhyay, Steven C. Mizell |
supervisoryBoard: | Kenneth C. Frazier, Christine E. Seidman, M.D., Inge Thulin, Kathy J. Warden, Mary Ellen Coe, Pamela J. Craig, Patricia F. Russo, Paul B. Rothman, M.D., Peter C. Wendell, Risa J. Lavizzo-Mourey, M.D., Robert M. Davis, Stephen L. Mayo, Thomas H. Glocer |
countryID: | 20 |
freeFloat: | 83.8400 |
faceValue: | 0.5000 |
faceValueCurrencyID: | 4 |
faceValueCurrency: | USD |
sectorName: | Pharmazeutische Industrie |
industryName: | Gesundheitswesen |
subsectorName: | Pharmazeutische Industrie |
country: | USA |
countryName: | USA |
Kontakt
name: | Teri Loxam |
phone: | +1-908-740-1986 |
email: | investor_relations@merck.com |
irWebSite: | https://www.merck.com/investor-relations/ |
Adresse
street: | 2000 Galloping Hill Road |
city: | Kenilworth, New Jersey 07033, USA |
phone: | +1-908-740-4000 |
webSite: | www.merck.com |
Finanzen (kurz)
year: | 2019 | cash: | 9676.0000 |
balanceSheetTotal: | 84397.0000 | liabilities: | 58396.0000 |
totalShareholdersEquity: | 26001.0000 | sales: | 46840.0000 |
incomeBeforeTaxes: | 11464.0000 | netIncome: | 9843.0000 |
cashFlow: | 1967.0000 | employees: | 71000 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
year: | 2020 | cash: | 8062.0000 |
balanceSheetTotal: | 91588.0000 | liabilities: | 66184.0000 |
totalShareholdersEquity: | 25404.0000 | sales: | 47994.0000 |
incomeBeforeTaxes: | 8791.0000 | netIncome: | 7067.0000 |
cashFlow: | -1769.0000 | employees: | 74000 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
year: | 2021 | cash: | 8096.0000 |
balanceSheetTotal: | 105694.0000 | liabilities: | 67437.0000 |
totalShareholdersEquity: | 38257.0000 | sales: | 48704.0000 |
incomeBeforeTaxes: | 13879.0000 | netIncome: | 13049.0000 |
cashFlow: | 14.0000 | employees: | 68000 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
Finanzen (kurz)
year: | 2019 |
cash: | 9676.0000 |
balanceSheetTotal: | 84397.0000 |
liabilities: | 58396.0000 |
totalShareholdersEquity: | 26001.0000 |
sales: | 46840.0000 |
incomeBeforeTaxes: | 11464.0000 |
netIncome: | 9843.0000 |
cashFlow: | 1967.0000 |
employees: | 71000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2020 |
cash: | 8062.0000 |
balanceSheetTotal: | 91588.0000 |
liabilities: | 66184.0000 |
totalShareholdersEquity: | 25404.0000 |
sales: | 47994.0000 |
incomeBeforeTaxes: | 8791.0000 |
netIncome: | 7067.0000 |
cashFlow: | -1769.0000 |
employees: | 74000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2021 |
cash: | 8096.0000 |
balanceSheetTotal: | 105694.0000 |
liabilities: | 67437.0000 |
totalShareholdersEquity: | 38257.0000 |
sales: | 48704.0000 |
incomeBeforeTaxes: | 13879.0000 |
netIncome: | 13049.0000 |
cashFlow: | 14.0000 |
employees: | 68000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
Finanzen (ausführlich)
year: | 2020 | units: | 1000000 |
balanceSheetTotal: | 91588.0000 | cash: | 8062.0000 |
currentAssets: | 27764.0000 | fixedAssets: | 63824.0000 |
liabilities: | 27327.0000 | totalLiabilitiesEquity: | 91588.0000 |
provisions: | 1015.0000 | totalShareholdersEquity: | 25404.0000 |
employees: | 74000 | property: | 17986.0000 |
intangibleAssets: | 14604.0000 | longTermInvestments: | 785.0000 |
inventories: | 6310.0000 | accountsReceivable: | 7851.0000 |
accountsPayable: | 4594.0000 | liabilitiesBanks: | 1674.0000 |
liabilitiesTotal: | 66184.0000 | longTermDebt: | 25360.0000 |
shortTermDebt: | 6431.0000 | minorityInterests: | 87.0000 |
sales: | 47994.0000 | netIncome: | 7067.0000 |
incomeInterest: | -886.0000 | investments: | 13558.0000 |
incomeTaxes: | 1709.0000 | costGoodsSold: | 15485.0000 |
grossProfit: | 47994.0000 | minorityInterestsProfit: | 4.0000 |
revenuePerEmployee: | 648567.5676 | cashFlow: | 10253.0000 |
cashFlowInvesting: | -9443.0000 | cashFlowFinancing: | -2832.0000 |
cashFlowTotal: | -1769.0000 | accountingStandard: | US GAAP |
equityRatio: | 27.7373 | debtEquityRatio: | 260.5259 |
liquidityI: | 29.5020 | liquidityII: | 58.2318 |
netMargin: | 14.7248 | grossMargin: | 100.0000 |
cashFlowMargin: | 21.3631 | ebitMargin: | 0.0000 |
ebitdaMargin: | 0.0000 | preTaxROE: | 34.6048 |
preTaxROA: | 9.5984 | roe: | 27.8185 |
roa: | 7.7161 | netIncomeGrowth: | -28.2028 |
revenuesGrowth: | 2.4637 | taxExpenseRate: | 19.4403 |
equityTurnover: | 1.8892 | epsBasic: | 2.7900 |
epsDiluted: | 2.7800 | epsBasicGrowth: | -27.3438 |
incomeBeforeTaxes: | 8791.0000 | priceEarningsRatioCompany: | 29.3190 |
priceCashFlowRatio: | 20.1872 | dividendYield: | 3.0318 |
bookValuePerShare: | 10.0399 | marketCap: | 206979821642.4000 |
earningsYield: | 3.4108 | pegRatio: | -1.0722 |
cashFlowPerShare: | 4.0521 | netAssetsPerShare: | 10.0742 |
priceBookValueRatio: | 8.1475 | dividendsPerShare: | 2.4800 |
priceEarningsRatio: | 29.2882 | netEarningsPerShare: | 2.7929 |
currency: | USD |
year: | 2021 | units: | 1000000 |
balanceSheetTotal: | 105694.0000 | cash: | 8096.0000 |
currentAssets: | 30266.0000 | fixedAssets: | 75428.0000 |
liabilities: | 23872.0000 | totalLiabilitiesEquity: | 105694.0000 |
provisions: | 3441.0000 | totalShareholdersEquity: | 38257.0000 |
employees: | 68000 | property: | 19279.0000 |
intangibleAssets: | 22933.0000 | longTermInvestments: | 370.0000 |
inventories: | 5953.0000 | accountsReceivable: | 9230.0000 |
accountsPayable: | 4609.0000 | liabilitiesBanks: | 1768.0000 |
liabilitiesTotal: | 67437.0000 | longTermDebt: | 30690.0000 |
shortTermDebt: | 2412.0000 | minorityInterests: | 73.0000 |
sales: | 48704.0000 | netIncome: | 13049.0000 |
incomeInterest: | -1341.0000 | investments: | 12245.0000 |
incomeTaxes: | 1521.0000 | costGoodsSold: | 13626.0000 |
grossProfit: | 48704.0000 | minorityInterestsProfit: | 13.0000 |
revenuePerEmployee: | 716235.2941 | cashFlow: | 13122.0000 |
cashFlowInvesting: | -16421.0000 | cashFlowFinancing: | 3097.0000 |
cashFlowTotal: | 14.0000 | accountingStandard: | US GAAP |
equityRatio: | 36.1960 | debtEquityRatio: | 176.2736 |
liquidityI: | 33.9142 | liquidityII: | 72.5788 |
netMargin: | 26.7925 | grossMargin: | 100.0000 |
cashFlowMargin: | 26.9423 | ebitMargin: | 0.0000 |
ebitdaMargin: | 0.0000 | preTaxROE: | 36.2783 |
preTaxROA: | 13.1313 | roe: | 34.1088 |
roa: | 12.3460 | netIncomeGrowth: | 84.6470 |
revenuesGrowth: | 1.4794 | taxExpenseRate: | 10.9590 |
equityTurnover: | 1.2731 | epsBasic: | 5.1600 |
epsDiluted: | 5.1400 | epsBasicGrowth: | 84.9462 |
incomeBeforeTaxes: | 13879.0000 | priceEarningsRatioCompany: | 14.8527 |
priceCashFlowRatio: | 14.7634 | dividendYield: | 3.4447 |
bookValuePerShare: | 15.1349 | marketCap: | 193725503563.8400 |
earningsYield: | 6.7328 | pegRatio: | 0.1748 |
cashFlowPerShare: | 5.1912 | netAssetsPerShare: | 15.1638 |
priceBookValueRatio: | 5.0638 | dividendsPerShare: | 2.6400 |
priceEarningsRatio: | 14.8460 | netEarningsPerShare: | 5.1623 |
currency: | USD |
year: | 2022 | priceEarningsRatioCompany: | 20.4225 |
priceCashFlowRatio: | 20.2997 | dividendYield: | 2.5052 |
bookValuePerShare: | 15.1349 | marketCap: | 267180027740.1200 |
earningsYield: | 4.8966 | pegRatio: | 0.2404 |
cashFlowPerShare: | 5.1912 | netAssetsPerShare: | 15.1349 |
priceBookValueRatio: | 6.9627 | priceEarningsRatio: | 20.4133 |
netEarningsPerShare: | 5.1623 | currency: | USD |
Finanzen (ausführlich)
year: | 2020 |
units: | 1000000 |
balanceSheetTotal: | 91588.0000 |
cash: | 8062.0000 |
currentAssets: | 27764.0000 |
fixedAssets: | 63824.0000 |
liabilities: | 27327.0000 |
totalLiabilitiesEquity: | 91588.0000 |
provisions: | 1015.0000 |
totalShareholdersEquity: | 25404.0000 |
employees: | 74000 |
property: | 17986.0000 |
intangibleAssets: | 14604.0000 |
longTermInvestments: | 785.0000 |
inventories: | 6310.0000 |
accountsReceivable: | 7851.0000 |
accountsPayable: | 4594.0000 |
liabilitiesBanks: | 1674.0000 |
liabilitiesTotal: | 66184.0000 |
longTermDebt: | 25360.0000 |
shortTermDebt: | 6431.0000 |
minorityInterests: | 87.0000 |
sales: | 47994.0000 |
netIncome: | 7067.0000 |
incomeInterest: | -886.0000 |
investments: | 13558.0000 |
incomeTaxes: | 1709.0000 |
costGoodsSold: | 15485.0000 |
grossProfit: | 47994.0000 |
minorityInterestsProfit: | 4.0000 |
revenuePerEmployee: | 648567.5676 |
cashFlow: | 10253.0000 |
cashFlowInvesting: | -9443.0000 |
cashFlowFinancing: | -2832.0000 |
cashFlowTotal: | -1769.0000 |
accountingStandard: | US GAAP |
equityRatio: | 27.7373 |
debtEquityRatio: | 260.5259 |
liquidityI: | 29.5020 |
liquidityII: | 58.2318 |
netMargin: | 14.7248 |
grossMargin: | 100.0000 |
cashFlowMargin: | 21.3631 |
ebitMargin: | 0.0000 |
ebitdaMargin: | 0.0000 |
preTaxROE: | 34.6048 |
preTaxROA: | 9.5984 |
roe: | 27.8185 |
roa: | 7.7161 |
netIncomeGrowth: | -28.2028 |
revenuesGrowth: | 2.4637 |
taxExpenseRate: | 19.4403 |
equityTurnover: | 1.8892 |
epsBasic: | 2.7900 |
epsDiluted: | 2.7800 |
epsBasicGrowth: | -27.3438 |
incomeBeforeTaxes: | 8791.0000 |
priceEarningsRatioCompany: | 29.3190 |
priceCashFlowRatio: | 20.1872 |
dividendYield: | 3.0318 |
bookValuePerShare: | 10.0399 |
marketCap: | 206979821642.4000 |
earningsYield: | 3.4108 |
pegRatio: | -1.0722 |
cashFlowPerShare: | 4.0521 |
netAssetsPerShare: | 10.0742 |
priceBookValueRatio: | 8.1475 |
dividendsPerShare: | 2.4800 |
priceEarningsRatio: | 29.2882 |
netEarningsPerShare: | 2.7929 |
currency: | USD |
year: | 2021 |
units: | 1000000 |
balanceSheetTotal: | 105694.0000 |
cash: | 8096.0000 |
currentAssets: | 30266.0000 |
fixedAssets: | 75428.0000 |
liabilities: | 23872.0000 |
totalLiabilitiesEquity: | 105694.0000 |
provisions: | 3441.0000 |
totalShareholdersEquity: | 38257.0000 |
employees: | 68000 |
property: | 19279.0000 |
intangibleAssets: | 22933.0000 |
longTermInvestments: | 370.0000 |
inventories: | 5953.0000 |
accountsReceivable: | 9230.0000 |
accountsPayable: | 4609.0000 |
liabilitiesBanks: | 1768.0000 |
liabilitiesTotal: | 67437.0000 |
longTermDebt: | 30690.0000 |
shortTermDebt: | 2412.0000 |
minorityInterests: | 73.0000 |
sales: | 48704.0000 |
netIncome: | 13049.0000 |
incomeInterest: | -1341.0000 |
investments: | 12245.0000 |
incomeTaxes: | 1521.0000 |
costGoodsSold: | 13626.0000 |
grossProfit: | 48704.0000 |
minorityInterestsProfit: | 13.0000 |
revenuePerEmployee: | 716235.2941 |
cashFlow: | 13122.0000 |
cashFlowInvesting: | -16421.0000 |
cashFlowFinancing: | 3097.0000 |
cashFlowTotal: | 14.0000 |
accountingStandard: | US GAAP |
equityRatio: | 36.1960 |
debtEquityRatio: | 176.2736 |
liquidityI: | 33.9142 |
liquidityII: | 72.5788 |
netMargin: | 26.7925 |
grossMargin: | 100.0000 |
cashFlowMargin: | 26.9423 |
ebitMargin: | 0.0000 |
ebitdaMargin: | 0.0000 |
preTaxROE: | 36.2783 |
preTaxROA: | 13.1313 |
roe: | 34.1088 |
roa: | 12.3460 |
netIncomeGrowth: | 84.6470 |
revenuesGrowth: | 1.4794 |
taxExpenseRate: | 10.9590 |
equityTurnover: | 1.2731 |
epsBasic: | 5.1600 |
epsDiluted: | 5.1400 |
epsBasicGrowth: | 84.9462 |
incomeBeforeTaxes: | 13879.0000 |
priceEarningsRatioCompany: | 14.8527 |
priceCashFlowRatio: | 14.7634 |
dividendYield: | 3.4447 |
bookValuePerShare: | 15.1349 |
marketCap: | 193725503563.8400 |
earningsYield: | 6.7328 |
pegRatio: | 0.1748 |
cashFlowPerShare: | 5.1912 |
netAssetsPerShare: | 15.1638 |
priceBookValueRatio: | 5.0638 |
dividendsPerShare: | 2.6400 |
priceEarningsRatio: | 14.8460 |
netEarningsPerShare: | 5.1623 |
currency: | USD |
year: | 2022 |
priceEarningsRatioCompany: | 20.4225 |
priceCashFlowRatio: | 20.2997 |
dividendYield: | 2.5052 |
bookValuePerShare: | 15.1349 |
marketCap: | 267180027740.1200 |
earningsYield: | 4.8966 |
pegRatio: | 0.2404 |
cashFlowPerShare: | 5.1912 |
netAssetsPerShare: | 15.1349 |
priceBookValueRatio: | 6.9627 |
priceEarningsRatio: | 20.4133 |
netEarningsPerShare: | 5.1623 |
currency: | USD |